Literature DB >> 12163615

The M184V mutation in reverse transcriptase can delay reversion of attenuated variants of simian immunodeficiency virus.

James B Whitney1, Maureen Oliveira, Mervi Detorio, Yongjun Guan, Mark A Wainberg.   

Abstract

We previously constructed a series of simian immunodeficiency virus (SIV) mutants containing deletions within a 97-nucleotide region of the SIVmac239 untranslated region or leader sequence. However, as is common with live attenuated viruses, several of the mutants exhibited a moderate propensity for reversion. Since the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase is associated with diminished fitness as well as lamivudine resistance, we introduced this substitution into several of our deletion mutants to determine its effects on viral replication and compensatory reversion. Our results indicate that M184V impaired viral fitness in pair-wise comparisons of mutants that contained or lacked this substitution. We also observed that M184V significantly impaired the potential for both compensatory mutagenesis and reversion in these mutants both in cell lines and in peripheral blood mononuclear cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163615      PMCID: PMC136968          DOI: 10.1128/jvi.76.17.8958-8962.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.

Authors:  C Liang; L Rong; Y Quan; M Laughrea; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 2.  Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology.

Authors:  I M Rouzine; A Rodrigo; J M Coffin
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

3.  Two alternating structures of the HIV-1 leader RNA.

Authors:  H Huthoff; B Berkhout
Journal:  RNA       Date:  2001-01       Impact factor: 4.942

4.  Novel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequences.

Authors:  Y Guan; J B Whitney; C Liang; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  trans-acting inhibition of genomic RNA dimerization by Rous sarcoma virus matrix mutants.

Authors:  R A Garbitt; J A Albert; M D Kessler; L J Parent
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis.

Authors:  M Götte; D Arion; M A Parniak; M A Wainberg
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Search for the mechanism of genetic variation in the pro gene of human immunodeficiency virus.

Authors:  I M Rouzine; J M Coffin
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.

Authors:  M T Burniston; A Cimarelli; J Colgan; S P Curtis; J Luban
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  The native structure of the human immunodeficiency virus type 1 RNA genome is required for the first strand transfer of reverse transcription.

Authors:  B Berkhout; A T Das; J L van Wamel
Journal:  Virology       Date:  1998-09-30       Impact factor: 3.616

10.  Dominance of the E89G substitution in HIV-1 reverse transcriptase in regard to increased polymerase processivity and patterns of pausing.

Authors:  Y Quan; P Inouye; C Liang; L Rong; M Götte; M A Wainberg
Journal:  J Biol Chem       Date:  1998-08-21       Impact factor: 5.157

View more
  6 in total

Review 1.  Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Karidia Diallo; Matthias Götte; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

Review 2.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  HIV-2 genome dimerization is required for the correct processing of Gag: a second-site reversion in matrix can restore both processes in dimerization-impaired mutant viruses.

Authors:  Anne L'Hernault; Eva U Weiss; Jane S Greatorex; Andrew M Lever
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

4.  Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.

Authors:  Hongzhao Li; Yan Hai; So-Yon Lim; Nikki Toledo; Jose Crecente-Campo; Dane Schalk; Lin Li; Robert W Omange; Tamara G Dacoba; Lewis R Liu; Mohammad Abul Kashem; Yanmin Wan; Binhua Liang; Qingsheng Li; Eva Rakasz; Nancy Schultz-Darken; Maria J Alonso; Francis A Plummer; James B Whitney; Ma Luo
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

5.  Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques.

Authors:  Hongzhao Li; Mikaela Nykoluk; Lin Li; Lewis R Liu; Robert W Omange; Geoff Soule; Lukas T Schroeder; Nikki Toledo; Mohammad Abul Kashem; Jorge F Correia-Pinto; Binhua Liang; Nancy Schultz-Darken; Maria J Alonso; James B Whitney; Francis A Plummer; Ma Luo
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

6.  Hypothetical endogenous SIV-like antigens in Mauritian cynomolgus macaques.

Authors:  Hongzhao Li; Lin Li; Lewis R Liu; Robert W Omange; Nikki Toledo; Mohammad Abul Kashem; Yan Hai; Binhua Liang; Francis A Plummer; Ma Luo
Journal:  Bioinformation       Date:  2018-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.